OMERS Administration Corp’s Beta Bionics BBNX Stock Holding History

OMERS Administration Corp’s Portfolio BBNX Stock Details BBNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$452K	Buy	+23,800	New	+$427K	﹤0.01%	814

Other funds holding BBNX

Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Sands Capital Ventures Arlington, Virginia $695M AUM 31.12% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

OMERS Administration Corp's BBNX Position: Q3 2026 in Review

OMERS Administration Corp opened a new position in Beta Bionics (BBNX) in Q3 2026: 23,800 shares worth $452K. The stake represents ﹤0.01% of the portfolio and ranks #814 among its holdings.

100 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

OMERS Administration Corp held 23,800 shares of Beta Bionics worth $452K as of Q3 2026.
Beta Bionics was a new OMERS Administration Corp position in Q3 2026.
Beta Bionics made up ﹤0.01% of OMERS Administration Corp's portfolio in Q3 2026, its #814 holding.
100 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on OMERS Administration Corp's 13F filing for Q3 2026, filed 13 Nov 2026.